• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旧辅料碳酸钙面临的新挑战:提高难溶性药物的溶出速率

A New Challenge for the Old Excipient Calcium Carbonate: To Improve the Dissolution Rate of Poorly Soluble Drugs.

作者信息

Ambrogi Valeria

机构信息

Department of Pharmaceutical Sciences, Via del Liceo 1, 06123 Perugia, Italy.

出版信息

Pharmaceutics. 2023 Jan 16;15(1):300. doi: 10.3390/pharmaceutics15010300.

DOI:10.3390/pharmaceutics15010300
PMID:36678929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9863708/
Abstract

Calcium carbonate is an excipient traditionally used in solid dosage forms with several functions such as a diluent, a quick dissolution agent, a buffer and an opacifier. Recently, many other challenges have arisen for calcium carbonate and, among them, the possibility of using it as an excipient for improving the dissolution rate of poorly soluble drugs. As a consequence of their poor solubility in biological fluids, many active ingredients suffer from low and erratic bioavailability when administered by the oral route and thus, many formulation strategies and excipients have been proposed to overcome this problem. Among them, calcium carbonate has been proposed as an excipient for improving dissolution rates. Calcium carbonate has many interesting characteristics, in fact it dissolves quickly in gastric fluid, is inexpensive and is safe. It exists in different polymorphic forms and in porous morphology and recently a porous functionalized calcium carbonate has been proposed as a new excipient. This review is the first overview on the use of calcium carbonate as an excipient for improving drug dissolution rates. The drug loading procedure, the physical characterization of the drug/CaCO samples and their dissolution profiles will be described. Moreover, the possible mechanisms of dissolution improvement, such as the presence of the drug in amorphous or polymorphic forms, in small crystals, and the effects of CaCO dissolution in acidic medium will be discussed. Different polymorphic forms of calcium carbonate and the presence of porosity and functionalization will be analyzed as well and their effects on dissolution rates will be discussed.

摘要

碳酸钙是传统上用于固体剂型的辅料,具有多种功能,如稀释剂、速溶剂、缓冲剂和遮光剂。最近,碳酸钙面临了许多其他挑战,其中包括将其用作提高难溶性药物溶出速率的辅料的可能性。由于许多活性成分在生物流体中的溶解度较差,口服给药时生物利用度低且不稳定,因此人们提出了许多制剂策略和辅料来克服这一问题。其中,碳酸钙已被提议作为提高溶出速率的辅料。碳酸钙具有许多有趣的特性,事实上它在胃液中溶解迅速、价格低廉且安全。它以不同的多晶型形式存在且具有多孔形态,最近一种多孔功能化碳酸钙已被提议作为一种新型辅料。本综述首次概述了碳酸钙作为提高药物溶出速率的辅料的应用。将描述药物负载过程、药物/碳酸钙样品的物理表征及其溶出曲线。此外,还将讨论溶出改善的可能机制,如药物以无定形或多晶型形式、小晶体形式存在,以及碳酸钙在酸性介质中溶解的影响。还将分析碳酸钙的不同多晶型形式以及孔隙率和功能化的存在,并讨论它们对溶出速率的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/c59d4fd4995e/pharmaceutics-15-00300-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/b2cd9dbcaee4/pharmaceutics-15-00300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/47372ec59361/pharmaceutics-15-00300-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/5fb3137dae43/pharmaceutics-15-00300-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/505577ccfc40/pharmaceutics-15-00300-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/208166193782/pharmaceutics-15-00300-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/c59d4fd4995e/pharmaceutics-15-00300-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/b2cd9dbcaee4/pharmaceutics-15-00300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/47372ec59361/pharmaceutics-15-00300-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/5fb3137dae43/pharmaceutics-15-00300-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/505577ccfc40/pharmaceutics-15-00300-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/208166193782/pharmaceutics-15-00300-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb8/9863708/c59d4fd4995e/pharmaceutics-15-00300-g006.jpg

相似文献

1
A New Challenge for the Old Excipient Calcium Carbonate: To Improve the Dissolution Rate of Poorly Soluble Drugs.旧辅料碳酸钙面临的新挑战:提高难溶性药物的溶出速率
Pharmaceutics. 2023 Jan 16;15(1):300. doi: 10.3390/pharmaceutics15010300.
2
Use of calcium carbonate as an excipient for release of poorly water soluble drugs: The case of carbamazepine.碳酸钙作为难溶性药物释放的赋形剂的应用:以卡马西平为例。
Int J Pharm. 2020 Nov 15;589:119860. doi: 10.1016/j.ijpharm.2020.119860. Epub 2020 Sep 7.
3
The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.功能性辅料在固体口服制剂中对克服药物溶出度差和生物利用度低的作用。
Pharmaceutics. 2020 Apr 25;12(5):393. doi: 10.3390/pharmaceutics12050393.
4
Ground Calcium Carbonate as a Low Cost and Biosafety Excipient for Solubility and Dissolution Improvement of Praziquantel.碳酸钙作为一种低成本且具有生物安全性的辅料用于提高吡喹酮的溶解度和溶出度。
Pharmaceutics. 2019 Oct 14;11(10):533. doi: 10.3390/pharmaceutics11100533.
5
On the mechanism of solubilization of drugs in the presence of poorly soluble additives.难溶性添加剂存在下药物的增溶机制
Int J Pharm. 2005 May 13;295(1-2):177-82. doi: 10.1016/j.ijpharm.2005.02.011.
6
Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances.介孔碳酸钙作为无定形塞来昔布的相稳定剂——提高难溶性药物生物利用度的一种方法。
Adv Healthc Mater. 2013 Nov;2(11):1469-76. doi: 10.1002/adhm.201200391. Epub 2013 May 23.
7
Drug loading into porous calcium carbonate microparticles by solvent evaporation.通过溶剂蒸发将药物载入多孔碳酸钙微粒中。
Eur J Pharm Biopharm. 2014 Aug;87(3):548-58. doi: 10.1016/j.ejpb.2014.02.009. Epub 2014 Feb 22.
8
Comparison of the liquisolid technique and co-milling for loading of a poorly soluble drug in inorganic porous excipients.比较液质同技术和共研磨技术在无机多孔辅料中载运难溶性药物的效果。
Int J Pharm. 2024 Jan 25;650:123702. doi: 10.1016/j.ijpharm.2023.123702. Epub 2023 Dec 10.
9
Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery.商业用介孔硅在口服药物传递中提高药物溶出度的应用。
Eur J Pharm Sci. 2021 Dec 1;167:106015. doi: 10.1016/j.ejps.2021.106015. Epub 2021 Sep 20.
10
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.用于提高难溶性药物溶出度和生物利用度的药物分散技术。
Pharmaceutics. 2018 Jun 23;10(3):74. doi: 10.3390/pharmaceutics10030074.

引用本文的文献

1
Effect of Monoethylene Glycol on the Nucleation and Growth of Calcium Carbonate from Supersaturated Solutions in Microchannels of Varying Wettability.单乙二醇对不同润湿性微通道中超饱和溶液中碳酸钙成核与生长的影响
Langmuir. 2025 Jun 3;41(21):13506-13515. doi: 10.1021/acs.langmuir.5c01363. Epub 2025 May 16.
2
Mechanism of Action of Dihydroquercetin in the Prevention and Therapy of Experimental Liver Injury.二氢槲皮素防治实验性肝损伤的作用机制。
Molecules. 2024 Jul 27;29(15):3537. doi: 10.3390/molecules29153537.

本文引用的文献

1
Calcium carbonate vaterite particles for drug delivery: Advances and challenges.用于药物递送的球霰石型碳酸钙颗粒:进展与挑战。
Mater Today Adv. 2022 Jun;14:100214. doi: 10.1016/j.mtadv.2022.100214. Epub 2022 Feb 12.
2
Advanced CaCO-derived delivery systems for bioactive compounds.高级 CaCO3 衍生递药系统用于生物活性化合物。
Adv Colloid Interface Sci. 2022 Nov;309:102791. doi: 10.1016/j.cis.2022.102791. Epub 2022 Sep 30.
3
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.难溶性药物和治疗剂的生物利用度提高技术
Biomedicines. 2022 Aug 23;10(9):2055. doi: 10.3390/biomedicines10092055.
4
Calcium carbonate: controlled synthesis, surface functionalization, and nanostructured materials.碳酸钙:控制合成、表面功能化和纳米结构材料。
Chem Soc Rev. 2022 Sep 20;51(18):7883-7943. doi: 10.1039/d1cs00519g.
5
Hard, Soft, and Hard--Soft Drug Delivery Carriers Based on CaCO and Alginate Biomaterials: Synthesis, Properties, Pharmaceutical Applications.基于碳酸钙和藻酸盐生物材料的硬、软及软硬结合药物递送载体:合成、性质及药物应用
Pharmaceutics. 2022 Apr 21;14(5):909. doi: 10.3390/pharmaceutics14050909.
6
Calcium carbonate nano- and microparticles: synthesis methods and biological applications.碳酸钙纳米颗粒和微米颗粒:合成方法及生物学应用
3 Biotech. 2021 Nov;11(11):457. doi: 10.1007/s13205-021-02995-2. Epub 2021 Oct 7.
7
Recent Technologies for Amorphization of Poorly Water-Soluble Drugs.难溶性药物非晶化的最新技术
Pharmaceutics. 2021 Aug 23;13(8):1318. doi: 10.3390/pharmaceutics13081318.
8
Use of calcium carbonate as an excipient for release of poorly water soluble drugs: The case of carbamazepine.碳酸钙作为难溶性药物释放的赋形剂的应用:以卡马西平为例。
Int J Pharm. 2020 Nov 15;589:119860. doi: 10.1016/j.ijpharm.2020.119860. Epub 2020 Sep 7.
9
CaCO crystals as versatile carriers for controlled delivery of antimicrobials.CaCO 晶体作为多功能载体用于控制释放抗菌药物。
J Control Release. 2020 Dec 10;328:470-489. doi: 10.1016/j.jconrel.2020.08.061. Epub 2020 Sep 5.
10
Functionalised calcium carbonate as a coformer to stabilize amorphous drugs by mechanochemical activation.功能化碳酸钙作为共晶形成剂通过机械化学活化来稳定无定形药物。
Eur J Pharm Biopharm. 2020 Oct;155:22-28. doi: 10.1016/j.ejpb.2020.07.029. Epub 2020 Aug 5.